Retinoids in combination therapies for the treatment of cancer: mechanisms and perspectives
- 1 June 2002
- journal article
- review article
- Published by Elsevier in Drug Resistance Updates
- Vol. 5 (3-4) , 162-175
- https://doi.org/10.1016/s1368-7646(02)00050-x
Abstract
No abstract availableKeywords
This publication has 84 references indexed in Scilit:
- NF-κB in cancer: from innocent bystander to major culpritNature Reviews Cancer, 2002
- Evidence of a lysosomal pathway for apoptosis induced by the synthetic retinoid CD437 in human leukemia HL-60 cellsCell Death & Differentiation, 2001
- All-trans retinoic acid and interferon-α in the treatment of a patient with resistant metastatic osteosarcomaCancer, 2000
- Apoptosis induction by arsenic: mechanisms of action and possible clinical applications for treating therapy-resistant cancersDrug Resistance Updates, 2000
- Interferon Alpha-2a and 13-cis-Retinoic Acid in Patients with Metastatic Renal Cell CancerCancer Investigation, 2000
- Treatment of High-Risk Neuroblastoma with Intensive Chemotherapy, Radiotherapy, Autologous Bone Marrow Transplantation, and 13-cis-Retinoic AcidNew England Journal of Medicine, 1999
- Activation of the p38 and JNK/SAPK Mitogen-Activated Protein Kinase Pathways during Apoptosis Is Mediated by a Novel RetinoidExperimental Cell Research, 1999
- The RXR heterodimers and orphan receptorsPublished by Elsevier ,1995
- Identification of synthetic retinoids with selectivity for human nuclear retinoic acid receptor γBiochemical and Biophysical Research Communications, 1992
- 13-cis-Retinoic Acid and Interferon -2a: Effective Combination. Therapy for Advanced Squamous Cell Carcinoma of the SkinJNCI Journal of the National Cancer Institute, 1992